Lisata Therapeutics annual gross margin
2010
2011
2012
2013
Lisata Therapeutics Gross Margin Growth & History (LSTA)
Lisata Therapeutics's gross margin was 11.73% for fiscal 2013.
View full Lisata Therapeutics company overviewLisata Therapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2013 | 2013-12-31 | 11.73% | −4.88 pp |
| 2012 | 2012-12-31 | 16.61% | +2.65 pp |
| 2011 | 2011-12-31 | 13.96% | −14.90 pp |
| 2010 | 2010-12-31 | 28.86% | — |
Lisata Therapeutics quarterly gross margin
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q4 2013 | 2013-12-31 | 18.00% | +9.23 pp |
| Q3 2013 | 2013-09-30 | 19.72% | +4.24 pp |
| Q2 2013 | 2013-06-30 | 2.85% | −16.01 pp |
| Q1 2013 | 2013-03-31 | 5.22% | −16.43 pp |
| Q4 2012 | 2012-12-31 | 8.77% | −4.36 pp |
| Q3 2012 | 2012-09-30 | 15.48% | −3.52 pp |
| Q2 2012 | 2012-06-30 | 18.86% | −8.26 pp |
| Q1 2012 | 2012-03-31 | 21.66% | −10.17 pp |
| Q3 2011 | 2011-09-30 | 13.12% | −20.35 pp |
| Q2 2011 | 2011-06-30 | 19.00% | — |
| Q1 2011 | 2011-03-31 | 27.13% | — |
| Q3 2010 | 2010-09-30 | 31.82% | — |
| Q2 2010 | 2010-06-30 | 33.47% | — |
Lisata Therapeutics gross margin trends
Across the available reported history, Lisata Therapeutics's gross margin decreased from 16.61% to 11.73%, a change of −4.88 percentage points. The latest reported quarter, Q4 2013, shows 18.00%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lisata Therapeutics filings at SEC.gov ↗